The Parkinsonism-associated protein DJ-1/Park7 prevents glycation damage in human keratinocyte

Tamara Advedissian1, Frédérique Deshayes1, Françoise Poirier1

  • 1Team Morphogénèse, Homéostasie et Pathologies, Univ Paris Diderot, Sorbonne Paris Cité, CNRS UMR 7592, Institut Jacques Monod, 15 Rue Hélène Brion, 75013, Paris, France.

Insights

DJ-1 (also known as Park7) is a protein deglycase that prevents protein glycation, a process linked to diabetic complications. This study shows DJ-1 protects skin cells from glycation, suggesting its importance in preventing skin aging and damage.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Dermatology

Background:

  • Protein glycation, caused by reducing sugars and dicarbonyls, inactivates proteins and is linked to diabetic complications.
  • DJ-1 (Park7) is a recently identified protein deglycase that repairs proteins damaged by glycation.
  • Glycation contributes to various diabetic complications, including skin defects.

Purpose of the Study:

  • To investigate the role of DJ-1 in preventing protein glycation in keratinocytes.
  • To determine if DJ-1 expression levels affect protein glycation in skin cells.
  • To explore DJ-1's potential in preventing skin glycation.

Main Methods:

  • Assessed collagen and keratinocyte protein glycation using ultraviolet absorption and fluorescence emission.
  • Utilized immunodetection with anti-advanced glycation endproduct antibodies in HaCaT keratinocytes.
  • Manipulated DJ-1 levels via small interfering RNAs (siRNAs) for depletion and plasmid transfection for overexpression.
  • Investigated the effect of Nrf2 inducer sulforaphane on DJ-1-mediated glycation prevention.

Main Results:

  • In vitro, DJ-1 demonstrated the ability to prevent the glycation of collagen and keratinocyte protein extracts.
  • Depletion of DJ-1 using siRNAs led to a threefold increase in protein glycation levels in HaCaT keratinocytes.
  • Overexpression of DJ-1, induced by sulforaphane or plasmid transfection, resulted in a significant, several-fold decrease in protein glycation.
  • DJ-1 was confirmed to play a crucial role in preventing protein glycation within eukaryotic cells.

Conclusions:

  • DJ-1 acts as a key deglycase, actively preventing protein glycation in skin cells.
  • DJ-1's protective function against glycation suggests its therapeutic potential for skin aging and diabetic skin complications.
  • DJ-1 is essential for maintaining protein integrity against glycation damage in eukaryotic cells.

Related Concept Videos

Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
10.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K